Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1041 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 123.18 USD | -4.00% | +3.16% | +28.92% | +75.65% | 7.51 B USD | ||
| 1048 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 112.50 USD | -1.71% | -0.84% | +28.35% | +1.99% | 7.71 B USD | ||
| 1083 |  LQDA Liquidia Corporation - Common Stock | 82.55 USD | +1.63% | +4.26% | +28.16% | +265.27% | 7.34 B USD | ||
| 1114 |  COGT Cogent Biosciences, Inc. - Common Stock | 38.64 USD | -3.42% | +0.42% | +21.17% | +146.59% | 6.60 B USD | ||
| 1122 |  SRRK Scholar Rock Holding Corporation - Common Stock | 55.02 USD | -2.72% | +1.96% | +23.78% | +83.28% | 6.59 B USD | ||
| 1162 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 311.75 USD | -2.40% | -1.61% | +28.83% | +66.60% | 6.25 B USD | ||
| 1171 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 64.27 USD | +1.42% | +7.15% | +23.26% | +57.56% | 6.21 B USD | ||
| 1184 |  CNTA Centessa Pharmaceuticals plc - American Depositary Shares | 40.50 USD | 0.00% | +1.07% | +1.94% | +65.17% | 6.27 B USD | ||
| 1238 |  CRSP CRISPR Therapeutics AG - Common Shares | 60.33 USD | -0.72% | +7.73% | +14.80% | +7.92% | 5.82 B USD | ||
| 1246 |  BLTE Belite Bio Inc - American Depositary Shares | 147.09 USD | -6.72% | -1.61% | +2.58% | +145.15% | 5.79 B USD | ||
| 1262 |  ERAS Erasca, Inc. - Common Stock | 18.17 USD | -1.03% | +1.91% | +37.44% | +1119.46% | 5.65 B USD | ||
| 1281 |  TVTX Travere Therapeutics, Inc. - Common Stock | 56.35 USD | -2.59% | -1.37% | +17.69% | +95.86% | 5.24 B USD | ||
| 1298 |  CELC Celcuity Inc. - Common Stock | 109.12 USD | -5.70% | +4.36% | +24.25% | +702.94% | 5.32 B USD | ||
| 1312 |  LEGN Legend Biotech Corporation - American Depositary Shares | 27.38 USD | -1.08% | -8.03% | -13.85% | -14.38% | 5.06 B USD | ||
| 1314 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 94.23 USD | -1.60% | +2.31% | +14.32% | +411.84% | 5.15 B USD | ||
| 1342 |  DFTX Definium Therapeutics, Inc. - Common Shares | 45.02 USD | +1.21% | +0.76% | +94.05% | +197.95% | 4.91 B USD | ||
| 1366 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.89 USD | +4.08% | +15.10% | +26.63% | +194.75% | 4.83 B USD | ||
| 1383 |  VKTX Viking Therapeutics, Inc. - Common Stock | 40.60 USD | -3.63% | +4.16% | +36.42% | +32.72% | 4.71 B USD | ||
| 1403 |  TNGX Tango Therapeutics, Inc. - Common Stock | 30.44 USD | +1.06% | +2.77% | -5.44% | +424.83% | 4.40 B USD | ||
| 1428 |  VCYT Veracyte, Inc. - Common Stock | 54.79 USD | -2.44% | -8.88% | +14.26% | +48.48% | 4.37 B USD |
Notícias Biotechnology Stocks
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Ação da Incyte atinge máxima de 52 semanas em US$ 118,77
Ações da Prime Medicine disparam após vitória em arbitragem contra a Beam
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |